Ohno T, Miyama-Inaba M, Masuda T, Fukuma K, Ajisaka K, Suzuki R, Kumagai K, Kanoh T, Uchino H
Immunology. 1987 May;61(1):35-41.
We investigated the effect of a lymphokine termed 'suppressive B-cell factor' (SBF), which is produced by FcR gamma (Fc receptor for IgG)-stimulated B cells or hybridoma TS4.44, and is known to suppress B-cell responses in vivo and in vitro by inhibiting their proliferation. Small B cells, fractionated by Percoll density gradient, from athymic nude mice (BALB/c) secreted SBF after binding EA (sheep erythrocytes sensitized with IgG mouse anti-sheep erythrocyte antibody), and the proliferation of small but not large B cells was preferentially suppressed by SBF in response to LPS in vitro. Proliferation of purified B cells from BALB/c nu/nu mice, induced by a synergistic interaction between F(ab')2 fragment of goat anti-mouse IgM antibody and B-cell stimulating factor (BSF1), was almost completely abrogated by the co-existence of SBF during the 72-hr culture period. However, the co-culture with SBF for the last 24 or 48 hr, as well as of B cells pretreated with SBF for 1 hr at 37 degrees, partially inhibited the growth response. These findings suggest that SBF operates on resting B cells and holds them in a resting state. This notion would be further supported by the fact that SBF inhibited G0-G1 transition. Taken together, we conclude that SBF acts on the early step of B-cell activation, thereby inhibiting B-cell growth. Arrest of resting B cells in the G0 phase and failure of an increase in functional receptors for BSF1 seem to be responsible for the suppression of B-cell responses.
我们研究了一种名为“抑制性B细胞因子”(SBF)的淋巴因子的作用,该因子由FcRγ(IgG的Fc受体)刺激的B细胞或杂交瘤TS4.44产生,已知其通过抑制B细胞增殖在体内和体外抑制B细胞反应。通过Percoll密度梯度分离的无胸腺裸鼠(BALB/c)的小B细胞在结合EA(用IgG小鼠抗绵羊红细胞抗体致敏的绵羊红细胞)后分泌SBF,并且在体外,SBF优先抑制小B细胞而非大B细胞对LPS的增殖反应。山羊抗小鼠IgM抗体的F(ab')2片段与B细胞刺激因子(BSF1)之间的协同相互作用诱导的BALB/c nu/nu小鼠纯化B细胞的增殖,在72小时培养期内由于SBF的共存几乎完全被消除。然而,在最后24或48小时与SBF共培养,以及在37℃用SBF预处理B细胞1小时,部分抑制了生长反应。这些发现表明SBF作用于静止B细胞并使其保持在静止状态。SBF抑制G0-G1期转换这一事实将进一步支持这一观点。综上所述,我们得出结论,SBF作用于B细胞活化的早期阶段,从而抑制B细胞生长。静止B细胞停滞在G0期以及BSF1功能性受体增加失败似乎是B细胞反应受到抑制的原因。